Finding cures for diseases like Parkinson’s means leaving no stone unturned. On the verge of developing a new kind of molecule to help combat the neurodegenerative condition, Ventus Therapeutics screened a documentary film about Parkinson’s for the entire company. The next day they invited a specialist to speak to everyone. On the third day, a patient with a severe form of Parkinson's shared his experience living with the disease. All three events were mandatory for employees, whether they were an accountant or a chemist. What was the impact? “Try telling someone at the company today that we’re giving up on Parkinson’s,” says CEO Marcelo Bigal. “They’re going to fight for it. The accountant is going to find money for Parkinson’s. This is our disease. Those events touched everyone at the company. They changed us.” Read our full Q&A with Bigal that spotlights how Ventus’s approach to drug discovery is unquestionably people-centered. https://lnkd.in/gveCgDTF #biotech #medicine #innovation
Great initiative to induce passion and innovative mindsets!! Marcelo Bigal please go through our research findings https://pubmed.ncbi.nlm.nih.gov/?term=Biswarup+ghosh%2C+smith+GM%2CParkinson%27s+Disease
Congrats. Save the science snd fhe researches. Good Luck and Long Life for humankind!
Nelson Costa
4w
Parabéns, Marcelo, for your collective unwavering commitment to patients.
Robert H.
4w
Great perspective Marcelo Bigal enjoyed your commentary here.
Executive Leader | Hospital Board Member| VPHuman Resources | CHRO | Biotech | Med Device | Startup | IPO | Public&Private | US,UK,Canada,Ireland
2wBy prioritizing awareness and understanding, Marcelo Bigal is not only enhancing corporate culture but also setting a benchmark for effective leadership. True leadership is about empowering employees with the right knowledge and tools to perform at their best. When leaders invest in the growth and well-being of their teams, it leads to higher engagement, motivation, and overall performance. Well Done!